Westpac Banking Corp
WBC
National Australia Bank Ltd
NAB
Origin Energy Ltd
ORG
ANZ Group Holdings Ltd
ANZ
CommBank
CBA
Wilsons Reaffirms Their Buy Rating on Clarity Pharmaceuticals Ltd. (CU6)
Wilsons Sticks to Its Buy Rating for Clarity Pharmaceuticals Ltd. (CU6)
Clarity Pharmaceuticals Price Target Raised 11% to A$8.20/Share by Jefferies
Bell Potter Remains a Buy on Clarity Pharmaceuticals Ltd. (CU6)
Clarity Pharmaceuticals Price Target Raised to A$10.00/Share From A$4.00 by Bell Potter
Jefferies Sticks to Their Buy Rating for Clarity Pharmaceuticals Ltd. (CU6)